{"id":"https://genegraph.clinicalgenome.org/r/233072f5-f943-4546-9108-71ba2b59d94cv1.0","type":"EvidenceStrengthAssertion","dc:description":"Variants in the FLNA gene were first reported in relation to X-linked periventricular nodular heterotopia in 1998 (Fox et al., PMID: 9883725). The majority of the affected individuals are female, while the affected males are typically prenatally or neonatally lethal. Common features include periventricular nodular heterotopia and epilepsy, while additional features such as cardiovascular abnormalities, connective tissue abnormalities, intellectual disability, and developmental delay have also been reported in some patients (Reinstein et al., PMID: 23032111; Parrini et al., PMID: 16684786; Tsuneda et al., PMID: 18427995).  Evidence supporting this gene-disease relationship includes case-level data. FLNA variants leading to periventricular nodular heterotopia have been reported in more than one hundred probands in the literature (PMID: 16684786, 18427995, 19917821, 23032111, 24089482, 26471271, and 29449050). Additionally, evidence supporting this gene-disease relationship includes animal models and in vitro rescue experiments (PMID: 16825286, 17172441, 22076441, and 24089482). Defects in the FLNA gene may also result in FG syndrome 2, X-linked cardiac valvular dysplasia, congenital short bowel syndrome, and neuronal intestinal pseudoobstruction, which all share overlapping phenotypes with some patients with periventricular nodular heterotopia (OMIM *300017). Of note, while loss-of-function variants in the FLNA gene lead to periventricular nodular heterotopia, gain-of-function variants cause X-linked otopalatodigital spectrum disorders (https://www.ncbi.nlm.nih.gov/books/NBK1393/). In summary, FLNA is definitively associated with X-linked periventricular nodular heterotopia. This has been repeatedly demonstrated in both the research and clinical diagnostic settings, and has been upheld over time. This classification was approved by the ClinGen Intellectual Disability and Autism Gene Curation Expert Panel on 12/27/20 (SOP Version 8).","dc:isVersionOf":"https://genegraph.clinicalgenome.org/r/233072f5-f943-4546-9108-71ba2b59d94c","GCISnapshot":"https://genegraph.clinicalgenome.org/r/80bc6280-7c21-4168-8a98-93c31fead5d7","calculatedEvidenceStrength":"Definitive","contributions":[{"id":"https://genegraph.clinicalgenome.org/r/80bc6280-7c21-4168-8a98-93c31fead5d7_publish_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10006","date":"2020-12-27T23:15:32.876Z","role":"Publisher"},{"id":"https://genegraph.clinicalgenome.org/r/80bc6280-7c21-4168-8a98-93c31fead5d7_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10006","date":"2020-12-27T23:11:55.213Z","role":"Approver"}],"evidence":[{"id":"https://genegraph.clinicalgenome.org/r/80bc6280-7c21-4168-8a98-93c31fead5d7_experimental_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/80bc6280-7c21-4168-8a98-93c31fead5d7_model_rescue_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/39d665ab-a8f3-44b9-824b-6b1549249159","type":"EvidenceLine","dc:description":"This is a knockdown instead of a knockout rat model. Although this publication showed an increased susceptibility to seizures in the knockdown rat model, the seizures experiment was induced by PTZ, a chemical convulsant that induces seizures by blocking the GABAA receptor-coupled chloride ionophore, instead of the spontaneous seizures observed in human patients.","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/cc45c9c4-73a2-4eba-902c-8d7a14b56bf1","type":"Finding","dc:description":"In FlnA-knockdown rats, the authors report that periventricular heterotopia results from a disruption of the polarized radial glial scaffold in the ventricular zone altering progression of neural progenitors through the cell cycle and impairing migration of neurons into the cortical plate.  Also, juvenile FlnA-knockdown rats are highly susceptible to seizures, confirming the reliability of this novel animal model of periventricular heterotopia. These findings suggest that the disorganization of radial glia is the leading cause of periventricular heterotopia pathogenesis associated with FLNA mutations.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/22076441","rdfs:label":"In utero RNA interference-mediated knockdown of FLNA in rat ","demonstrates":{"id":"cg:ProteinAlterationDisruptsOrganismFunction"}}],"specifiedBy":"GeneValidityNonHumanModelOrganismCriteria","strengthScore":"0.5"},{"id":"https://genegraph.clinicalgenome.org/r/ee73eba2-bc15-4edc-97be-f08d29bfaed0","type":"EvidenceLine","dc:description":"The prolonged survival of this mouse model by breeding onto an s129/sv strain allows the detection of neuronal migration defects not seen in PMID: 24089482. However, the neuronal migration defects were reported only in male FlnA-null mice (embryonic lethality) but not further investigated in viable female heterozygous mice.","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/39a08ae8-c099-4a43-a2d7-b7d60b5b53ab","type":"Finding","dc:description":"Loss of FLNA impairs neuronal migration in vivo. Periventricular heterotopia seen in patients with loss-of-function variants in FLNA is resulting from a migration defect of the ectopic neuronal nodules around ventricle lining during early brain development.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/24089482","rdfs:label":"A mouse model with FLNA Y2388X variant ","demonstrates":{"id":"cg:ProteinAlterationDisruptsOrganismFunction"}}],"specifiedBy":"GeneValidityNonHumanModelOrganismCriteria","strengthScore":"0.5"},{"id":"https://genegraph.clinicalgenome.org/r/0a079a61-ba78-448f-a07a-7bd3351206b3","type":"EvidenceLine","dc:description":"Although this conditional knockout mouse model recapitulated the abnormality of cardiovascular system morphology seen in patients, the migration and motility of many cell types does not appear to be affected as many FLNA mutant neurons still successfully migrate to the cerebral cortex. Viable heterozygous female mice showed no neuronal heterotopia at 1â€“3 months of age. No behavioral tests were carried out in this publication.","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/66c7dd50-f65e-4bb2-967d-449523c9e0c5","type":"Finding","dc:description":"Complete loss of Flna in mice results in embryonic lethality with severe cardiac structural defects involving ventricles, atria, and outflow tracts, as well as widespread aberrant vascular patterning. Flna-null embryos display abnormal epithelial and endothelial organization and aberrant adherens junctions in developing blood vessels, heart, brain, and other tissues. Essential roles for FLNA in intercellular junctions provide a mechanism for the diverse developmental defects seen in patients with FLNA mutations","dc:source":"https://pubmed.ncbi.nlm.nih.gov/17172441","rdfs:label":"Conditional knockout of FLNA in mice","demonstrates":{"id":"cg:ProteinAlterationDisruptsOrganismFunction"}}],"specifiedBy":"GeneValidityNonHumanModelOrganismCriteria","strengthScore":"0.25"},{"id":"https://genegraph.clinicalgenome.org/r/ed30e1ca-bcf6-4b6c-8685-a563a750a1c5","type":"EvidenceLine","dc:description":"Although this ENU-induced mouse model (corresponding to FLNA c.7164T>A (p.Tyr2388Ter) in human) recapitulated certain abnormality of cardiovascular system morphology seen in patients, no cell morphology or migration defects were observed in the mouse fibroblast cells. No periventricular nodular heterotopia was observed in five carrier female mice tested. ","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/ea5d0fe4-6d88-4fed-a2e0-5ce897e17496","type":"Finding","dc:description":"A mouse model with FLNA Y2388X variant leads to absence of the Flna protein and male lethality because of incomplete septation of the outflow tract of the heart, which produces common arterial trunk. A proportion of both male and female mutant mice have other cardiac defects including ventricular septal defect. Mutant males have midline fusion defects manifesting as sternum and palate abnormalities. Carrier females exhibit milder sternum and palate defects and misshapen pupils. These results define crucial roles for Flna in development,  suggesting possible explanations for lethality of human males hemizygous for null alleles of FLNA.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/16825286","rdfs:label":"A mouse model with FLNA Y2388X variant ","demonstrates":{"id":"cg:ProteinAlterationDisruptsOrganismFunction"}}],"specifiedBy":"GeneValidityNonHumanModelOrganismCriteria","strengthScore":"0.1"},{"id":"https://genegraph.clinicalgenome.org/r/60473a05-0758-491b-b0c5-71b725c72137","type":"EvidenceLine","dc:description":"This is a rescue experiment in a knockdown rat model, resulting in a partial rescue of radial neuronal migration defects in the intermediate zones (but not other brain regions).","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/1d96fc1d-6c92-48e0-b4e8-912bd976732f","type":"Finding","dc:description":"Transfections of FlnA-IRES-GFP (full-length FlnA ) construct in the knockdown experiments partially rescued the radial neuronal migration defects in the intermediate zones.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/22076441","rdfs:label":"Rescue of the radial migration defect in knockdown neurons ","demonstrates":{"id":"cg:PhenotypeRescue"}}],"specifiedBy":"GeneValidityNonHumanRescueCriteria","strengthScore":"0.5"}],"specifiedBy":"GeneValidityOverallModelAndRescueEvidenceCriteria","strengthScore":1.85}],"specifiedBy":"GeneValidityOverallExperimentalEvidenceCriteria","strengthScore":1.85},{"id":"https://genegraph.clinicalgenome.org/r/80bc6280-7c21-4168-8a98-93c31fead5d7_overall_genetic_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/80bc6280-7c21-4168-8a98-93c31fead5d7_ad_dn_el","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/7e2d1db1-1caf-4509-af52-13cbbda256d7_proband_score_evidence_line","type":"EvidenceLine","dc:description":"This is a de novo frameshift variant.","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/200d60e0-a019-45a4-9b68-fe4a59b24e94","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/19917821","rdfs:label":"11","ageType":"AgeAtReport","ageUnit":"Years","ageValue":4,"firstTestingMethod":"Denaturing gradient gel","phenotypes":["obo:HP_0007165","obo:HP_0001250","obo:HP_0001643"],"secondTestingMethod":"Sanger sequencing","sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/7e2d1db1-1caf-4509-af52-13cbbda256d7_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/19917821","allele":{"id":"https://genegraph.clinicalgenome.org/r/bcc7d619-16e5-410d-a950-c0be3650303b","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001110556.2(FLNA):c.1789_1790del (p.Phe597CysfsTer23)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA1139655030"}},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"},"paternityMaternityConfirmed":"none"}}],"specifiedBy":"GeneValidityProbandADDeNovoCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/29bf9afe-6f15-4be5-80d8-a0092b1a72ea_proband_score_evidence_line","type":"EvidenceLine","dc:description":"This is a de novo nonsense variant.","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/37c36c2c-3205-4017-9592-1c4d75e29223","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/29449050","rdfs:label":"1","ageType":"AgeAtReport","ageUnit":"Years","ageValue":4,"ethnicity":{"id":"cg:NotHispanicOrLatino"},"firstTestingMethod":"Sanger sequencing","phenotypes":["obo:HP_0002280","obo:HP_0007165","obo:HP_0002092","obo:HP_0002933","obo:HP_0002098","obo:HP_0001643","obo:HP_0004970","obo:HP_0001873","obo:HP_0001270","obo:HP_0009110","obo:HP_0001659"],"sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/29bf9afe-6f15-4be5-80d8-a0092b1a72ea_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/29449050","allele":{"id":"https://genegraph.clinicalgenome.org/r/71d39742-b0c9-460a-a13c-06d0476f6dfe","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001110556.2(FLNA):c.1621G>T (p.Glu541Ter)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA337283196"}},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"},"paternityMaternityConfirmed":"none"}}],"specifiedBy":"GeneValidityProbandADDeNovoCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/c6d6cafc-98cb-4ce0-8572-e9734b7482e6_proband_score_evidence_line","type":"EvidenceLine","dc:description":"This is a de novo nonsense variant.","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/cc71e0f7-85b3-4f3c-9d95-4676a49becf0","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/19917821","rdfs:label":"2","ageType":"AgeAtReport","ageUnit":"Years","ageValue":52,"firstTestingMethod":"Denaturing gradient gel","phenotypes":["obo:HP_0030890","obo:HP_0007165","obo:HP_0200067","obo:HP_0001250","obo:HP_0002280"],"secondTestingMethod":"Sanger sequencing","sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/c6d6cafc-98cb-4ce0-8572-e9734b7482e6_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/19917821","allele":{"id":"https://genegraph.clinicalgenome.org/r/142a410a-8edc-4955-8b35-64d51dc71210","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001110556.2(FLNA):c.957C>A (p.Tyr319Ter)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA415247613"}},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"},"paternityMaternityConfirmed":"none"}}],"specifiedBy":"GeneValidityProbandADDeNovoCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/fbad633a-ce1b-40f5-b26d-4d1a8f323d11_proband_score_evidence_line","type":"EvidenceLine","dc:description":"This is a de novo nonsense variant.","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/76f58e50-2bf1-4440-af54-c6d686a91458","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/23032111","rdfs:label":"F3","ageType":"AgeAtReport","ageUnit":"Years","ageValue":6,"firstTestingMethod":"Sanger sequencing","phenotypes":["obo:HP_0004927","obo:HP_0000750","obo:HP_0001388","obo:HP_0000961","obo:HP_0030962","obo:HP_0100962","obo:HP_0005176","obo:HP_0000739","obo:HP_0030732","obo:HP_0001643","obo:HP_0007165","obo:HP_0005164","obo:HP_0010648","obo:HP_0002092"],"sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/fbad633a-ce1b-40f5-b26d-4d1a8f323d11_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/23032111","allele":{"id":"https://genegraph.clinicalgenome.org/r/33e50170-8251-4752-a9bf-fa1c5ddb2396","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001110556.2(FLNA):c.2193C>A (p.Tyr731Ter)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA415237976"}},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"},"paternityMaternityConfirmed":"none"}}],"specifiedBy":"GeneValidityProbandADDeNovoCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/d5da1353-e3b1-4664-bf1f-5160794e9235_proband_score_evidence_line","type":"EvidenceLine","dc:description":"This de novo frameshift variant passed on to the similarly affected daughter.","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/4053cc48-19f9-40a9-8da7-8a2e5b34b9bc","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/23032111","rdfs:label":"F1","ageType":"AgeAtReport","ageUnit":"Years","ageValue":38,"firstTestingMethod":"Sanger sequencing","phenotypeFreeText":"mild cystic medial degeneration in aortic tissue, diffuse ectasia of aortic branch vessels","phenotypes":["obo:HP_0001388","obo:HP_0000977","obo:HP_0007165","obo:HP_0011645","obo:HP_0000978"],"sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/d5da1353-e3b1-4664-bf1f-5160794e9235_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/23032111","allele":{"id":"https://genegraph.clinicalgenome.org/r/598c8cbc-11fc-4b83-9071-877cb2bdf164","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001110556.2(FLNA):c.885_892del (p.Asn296GlufsTer38)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA10587974"}},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"},"paternityMaternityConfirmed":"none"}}],"specifiedBy":"GeneValidityProbandADDeNovoCriteria","strengthScore":2}],"specifiedBy":"GeneValidityOverallAutosomalDominantDeNovoVariantEvidenceCriteria","strengthScore":10},{"id":"https://genegraph.clinicalgenome.org/r/80bc6280-7c21-4168-8a98-93c31fead5d7_ad_null_el","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/251f52a4-00c1-485e-8ad5-efd58c7d4789_proband_score_evidence_line","type":"EvidenceLine","dc:description":"The variant was identified by single candidate gene sequencing.","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/fa553893-fd90-4e45-b8f2-96a1a5ffe15e","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/19917821","rdfs:label":"24","ageType":"AgeAtReport","ageUnit":"Years","ageValue":3,"firstTestingMethod":"Denaturing gradient gel","phenotypes":["obo:HP_0001250","obo:HP_0007165","obo:HP_0001999"],"secondTestingMethod":"Sanger sequencing","sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/251f52a4-00c1-485e-8ad5-efd58c7d4789_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/19917821","allele":{"id":"https://genegraph.clinicalgenome.org/r/1c7fd123-93a6-4ec5-913e-33a778789323","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001110556.2(FLNA):c.2587C>T (p.Arg863Ter)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA415233592"}},"paternityMaternityConfirmed":"none"}}],"specifiedBy":"GeneValidityProbandADNullCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/33f49199-382f-4a19-981c-74d2d5e462df_proband_score_evidence_line","type":"EvidenceLine","dc:description":"The variant was identified by single candidate gene sequencing.","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/b7f8ec13-1c93-48ec-ae2e-a96dc3923d66","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/19917821","rdfs:label":"14","ageType":"AgeAtReport","ageUnit":"Years","ageValue":32,"firstTestingMethod":"Denaturing gradient gel","phenotypes":["obo:HP_0001250","obo:HP_0001321","obo:HP_0007165"],"secondTestingMethod":"Sanger sequencing","sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/33f49199-382f-4a19-981c-74d2d5e462df_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/19917821","allele":{"id":"https://genegraph.clinicalgenome.org/r/8d57f638-4a87-4372-bef8-6f623ee6c613","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001110556.2(FLNA):c.3768dup (p.Gly1257ArgfsTer10)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA1139655031"}},"paternityMaternityConfirmed":"none"}}],"specifiedBy":"GeneValidityProbandADNullCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/6a1636b7-8ccb-4a04-a5b7-6dd3f549a9b7_proband_score_evidence_line","type":"EvidenceLine","dc:description":"The variant was identified by single candidate gene sequencing.","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/8e31f6b5-4313-478a-bc3a-93871d2df8a8","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/19917821","rdfs:label":"16","ageType":"AgeAtReport","ageUnit":"Years","ageValue":41,"firstTestingMethod":"Denaturing gradient gel","phenotypes":["obo:HP_0001321","obo:HP_0002119","obo:HP_0030890","obo:HP_0001249","obo:HP_0002084","obo:HP_0007165","obo:HP_0001250"],"secondTestingMethod":"Sanger sequencing","sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/6a1636b7-8ccb-4a04-a5b7-6dd3f549a9b7_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/19917821","allele":{"id":"https://genegraph.clinicalgenome.org/r/267cd090-3bb8-465d-abb9-48f04340ced7","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001110556.2(FLNA):c.4574dup (p.Tyr1525Ter)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA1139655028"}},"paternityMaternityConfirmed":"none"}}],"specifiedBy":"GeneValidityProbandADNullCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/773e2f46-644e-4153-9549-6786639f94b1_proband_score_evidence_line","type":"EvidenceLine","dc:description":"The mother and the two sisters were all affected and carried the variant. ","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/c6513541-b289-42bf-b640-57e0d7c3469b","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/16684786","rdfs:label":"7b","ageType":"AgeAtReport","ageUnit":"Years","ageValue":33,"firstTestingMethod":"Denaturing gradient gel","phenotypes":["obo:HP_0001250","obo:HP_0007165","obo:HP_0200067"],"secondTestingMethod":"Sanger sequencing","sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/773e2f46-644e-4153-9549-6786639f94b1_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/16684786","allele":{"id":"https://genegraph.clinicalgenome.org/r/37dc2942-b82e-4452-9757-b94842a91faa","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001110556.2(FLNA):c.4265_4266delinsGA (p.Tyr1422Ter)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA1139655029"}},"paternityMaternityConfirmed":"none"}}],"specifiedBy":"GeneValidityProbandADNullCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/60e2e1ea-2424-4c0c-bcbb-376c9209657b_proband_score_evidence_line","type":"EvidenceLine","dc:description":"This canonical splice site variant was inherited from the similarly affected mother.","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/3304e20f-d2a3-49be-b122-f044c13cbfac","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/19917821","rdfs:label":"6","ageType":"AgeAtReport","ageUnit":"Years","ageValue":29,"firstTestingMethod":"Denaturing gradient gel","phenotypes":["obo:HP_0007165","obo:HP_0001250","obo:HP_0002795","obo:HP_0200067"],"secondTestingMethod":"Sanger sequencing","sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/60e2e1ea-2424-4c0c-bcbb-376c9209657b_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/19917821","allele":{"id":"https://genegraph.clinicalgenome.org/r/50a418cc-009a-4e36-bfd3-4ba8021f49b7","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001110556.2(FLNA):c.1828+2T>G (p.=)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA415242176"}},"paternityMaternityConfirmed":"none"}}],"specifiedBy":"GeneValidityProbandADNullCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/6b2d0389-767c-4c13-b49c-08346794c18d_proband_score_evidence_line","type":"EvidenceLine","dc:description":"This variant was also detected in the similarly affected mother. mRNA studies in the lymphocytes of fresh blood from the patient showed intron 6 inclusion, leading to a frameshift and premature protein termination. The maternal history of five miscarriages is suggestive of lethality in affected males.","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/508111f1-62c6-4019-8624-1d28cee27134","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/18427995","rdfs:label":"Patient 1","ageType":"AgeAtReport","ageUnit":"Years","ageValue":28,"firstTestingMethod":"SSCP","phenotypes":["obo:HP_0001250","obo:HP_0001249","obo:HP_0001263","obo:HP_0007165"],"secondTestingMethod":"Sanger sequencing","sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/6b2d0389-767c-4c13-b49c-08346794c18d_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/18427995","allele":{"id":"https://genegraph.clinicalgenome.org/r/8d509847-34a7-49fc-9f6c-11a4359f88e9","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001110556.2(FLNA):c.987G>C (p.Glu329Asp)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA415247446"}},"paternityMaternityConfirmed":"none"}}],"specifiedBy":"GeneValidityProbandADNullCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/5397823a-a440-4727-bdaf-6a6291973d39_proband_score_evidence_line","type":"EvidenceLine","dc:description":"This synonymous variant was also detected in the similarly affected sister. However, the inheritance is unclear in the publication. mRNA studies in the patient-derived lymphoblastoid cells confirmed that this variant leads to nonsense-mediated decay.  ","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/c0225d11-58a8-42fa-92c2-2104d137616f","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/16684786","rdfs:label":"2a","ageType":"AgeAtReport","ageUnit":"Years","ageValue":20,"firstTestingMethod":"Denaturing gradient gel","phenotypes":["obo:HP_0007165","obo:HP_0002315","obo:HP_0006889","obo:HP_0031258"],"secondTestingMethod":"Sanger sequencing","sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/5397823a-a440-4727-bdaf-6a6291973d39_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/16684786","allele":{"id":"https://genegraph.clinicalgenome.org/r/ec6490db-20e6-4011-a35b-ee697fa71195","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001110556.2(FLNA):c.5154C>T (p.Gly1718=)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA519707246"}},"paternityMaternityConfirmed":"none"}}],"specifiedBy":"GeneValidityProbandADNullCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/f1b2716d-fa9e-4bc5-89fe-b1ab63afe4b5_proband_score_evidence_line","type":"EvidenceLine","dc:description":"The variant was identified by single candidate gene sequencing.","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/4cbc0381-48e6-4280-86d7-fdb5f78f1f04","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/16684786","rdfs:label":"15","ageType":"AgeAtReport","ageUnit":"Years","ageValue":23,"detectionMethod":"The authors carried out mutation screening of the coding regions of FLNA by denaturing high performance liquid chromatography (DHPLC). PCR products that showed an alteration in the DHPLC elution profile were purified and cycle sequenced on both strands.","firstTestingMethod":"Denaturing gradient gel","phenotypes":["obo:HP_0100543","obo:HP_0007165","obo:HP_0001250"],"secondTestingMethod":"Sanger sequencing","sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/f1b2716d-fa9e-4bc5-89fe-b1ab63afe4b5_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/16684786","allele":{"id":"https://genegraph.clinicalgenome.org/r/5c6deba9-40a0-41ea-a3f1-f9abfdc48b51","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001110556.2(FLNA):c.6287_6288insAA (p.Asp2096GlufsTer?)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA1139532201"}}}}],"specifiedBy":"GeneValidityProbandADNullCriteria","strengthScore":1}],"specifiedBy":"GeneValidityOverallAutosomalDominantNullVariantEvidenceCriteria","strengthScore":10}],"specifiedBy":"GeneValidityOverallGeneticEvidenceCriteria","strengthScore":12}],"evidenceStrength":"Definitive","sequence":1653,"specifiedBy":"GeneValidityCriteria8","strengthScore":13.85,"subject":{"id":"https://genegraph.clinicalgenome.org/r/7O9sWZlgbnM","type":"GeneValidityProposition","disease":"obo:MONDO_0020341","gene":"hgnc:3754","modeOfInheritance":"obo:HP_0001417"},"version":"1.0","websiteLegacyID":"https://genegraph.clinicalgenome.org/r/assertion_80bc6280-7c21-4168-8a98-93c31fead5d7-","@context":{"@vocab":"https://genegraph.clinicalgenome.org/terms/","id":"@id","type":"@type","cg":"https://genegraph.clinicalgenome.org/terms/","dc":"http://purl.org/dc/terms/","obo":"http://purl.obolibrary.org/obo/","hgnc":"https://identifiers.org/hgnc:","rdfs":"http://www.w3.org/2000/01/rdf-schema#","cggv":"https://genegraph.clinicalgenome.org/r/gci/","evidenceStrength":{"@type":"@vocab"},"calculatedEvidenceStrength":{"@type":"@vocab"},"computedEvidenceStrength":{"@type":"@vocab"},"specifiedBy":{"@type":"@vocab"},"evidence":{"@container":"@set"},"disease":{"@type":"@vocab"},"gene":{"@type":"@vocab"},"phenotypes":{"@type":"@id"},"agent":{"@type":"@id"},"role":{"@type":"@vocab"},"modeOfInheritance":{"@type":"@vocab"},"sex":{"@type":"@vocab"},"direction":{"@type":"@vocab"},"ageType":{"@type":"@vocab"},"ageUnit":{"@type":"@vocab"},"dc:source":{"@type":"@id"},"curationReasons":{"@type":"@vocab","@container":"@set"},"GCISnapshot":{"@type":"@id"},"dc:isVersionOf":{"@type":"@id"},"websiteLegacyID":{"@type":"@id"}}}